Archive Newsletter

  1. 05.29.26 -- Materials Matter: Reframing Raw Material Strategy In Cell And Gene Therapy Development 5/29/2026
    05/29/26
  2. 05.28.26 -- Accelerate Your Assay And Imaging Data With These New Tools 5/28/2026
    05/28/26 Cell & Gene Newsletter
  3. 05.28.26 -- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook 5/28/2026
    05/28/26 Cell & Gene Newsletter
  4. 05.27.26 -- Smarter Processing For Workflows From Discovery To Commercial Scale 5/27/2026
    05/27/26 Cell & Gene Newsletter
  5. 05.27.26 -- Rethinking Sterile Welding In Bioprocessing 5/27/2026

    05/27/26 Cell & Gene Newsletter

  6. 05.27.26 -- Bridging Analytical Gaps To Ensure CGT Material Quality 5/27/2026
    05/27/26 Cell & Gene Newsletter
  7. 05.26.26 -- Why Material Definitions Matter In Cell And Gene Therapy 5/26/2026
    05/26/26 Cell & Gene Newsletter
  8. 05.26.26 -- Spine Care Redefined: Autologous Cell Therapy For Degenerative Disc Disease 5/26/2026
    05/26/26 Cell & Gene Newsletter
  9. 05.22.26 -- Scaling RNA & LNP Manufacturing With Smarter Analytics 5/22/2026
    05/22/26 Cell & Gene Newsletter
  10. 05.22.26 -- Inside March Biosciences' CD5-Targeting CAR-T Approach 5/22/2026
    05/22/26 Cell & Gene Newsletter